| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 1, 2018Pharmaceutical Business Development Leader Dr. Kevin Lynch Joins Recursion as Chief Business Officer
Recursion Pharmaceuticals, a biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover drugs at scale, today announced it has hired Kevin...
-
Jun 28, 2017Former Bristol-Myers Squibb scientist and regulatory affairs expert joins Recursion
Recursion Pharmaceuticals, an emerging biotechnology company today announced it has hired Dr. Chand Sishta as the senior director of regulatory affairs. Chand joins the company after 25 years in...
-
Apr 28, 2017Bengio to advise on Recursion's unique approach to discovering new therapies for rare genetic diseases at the intersection of deep learning and biology
Recursion Pharmaceuticals, an emerging biotechnology company that combines innovative biological science with machine learning techniques to discover treatments for rare genetic diseases, today...
-
Apr 18, 2017Former Johnson & Johnson scientist will expand Recursion's drug discovery capabilities
Recursion Pharmaceuticals, an emerging biotechnology company that combines innovative biological science with machine learning techniques to discover treatments for rare genetic diseases, today...